Literature DB >> 1334198

Expression of a carboxy-terminal region of the beta-amyloid precursor protein in a heterogeneous culture of neuroblastoma cells: evidence for altered processing and selective neurotoxicity.

K Fukuchi1, K Kamino, S S Deeb, C E Furlong, J A Sundstrom, A C Smith, G M Martin.   

Abstract

Six independent clonal isolates from a morphologically heterogeneous human neuroblastoma cell line stably expressed several products of the human amyloid precursor protein (APP) from an introduced DNA construct; the "substrate-adherent" phenotype (fibroblast-like cells) predominated in all 6; these displayed immunoreactivity of vimentin, but little to no reactivity of neuron-specific enolase. A stably transfected isolate which did not show any expression from the identical construct (presumably because of a position effect) exhibited the predominantly neuronal phenotype of the parental cells (neuron-specific enolase positive). These results suggest selective neurotoxicity of the expressed products. Two of the 6 stably expressing cell lines showed a decrease of native mRNA for APP to levels that were 1/4-1/3 that of the parental cells and a decrease of their growth rates to half that of the parental cells; these decreased growth rates were improved by conditioned medium from the parental cell line. Western blot analysis revealed at least four distinct fragments of the COOH-terminus of APP in the isolate which expressed protein and mRNA in greatest abundance, suggesting that overexpression of APP in a human neural cell line leads to aberrant cleavage of APP.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1334198     DOI: 10.1016/0169-328x(92)90191-d

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  7 in total

1.  Generating differentially targeted amyloid-beta specific intrabodies as a passive vaccination strategy for Alzheimer's disease.

Authors:  Kelly L Sudol; Michael A Mastrangelo; Wade C Narrow; Maria E Frazer; Yona R Levites; Todd E Golde; Howard J Federoff; William J Bowers
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

Review 2.  Versatile somatic gene transfer for modeling neurodegenerative diseases.

Authors:  Ronald L Klein; David B Wang; Michael A King
Journal:  Neurotox Res       Date:  2009-08-11       Impact factor: 3.911

3.  High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.

Authors:  K Fukuchi; L Ho; S G Younkin; D D Kunkel; C E Ogburn; R C LeBoeuf; C E Furlong; S S Deeb; D Nochlin; J Wegiel; H M Wisniewski; G M Martin
Journal:  Am J Pathol       Date:  1996-07       Impact factor: 4.307

4.  Expression of the C terminus of the amyloid precursor protein alters growth factor responsiveness in stably transfected PC12 cells.

Authors:  F A Sandhu; Y Kim; K A Lapan; M Salim; V Aliuddin; S B Zain
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

5.  Biochemical and electrophysiological differentiation profile of a human neuroblastoma (IMR-32) cell line.

Authors:  Raj R Rao; William S Kisaalita
Journal:  In Vitro Cell Dev Biol Anim       Date:  2002-09       Impact factor: 2.416

6.  Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis.

Authors:  L W Jin; M G Hearn; C E Ogburn; N Dang; D Nochlin; W C Ladiges; G M Martin
Journal:  Am J Pathol       Date:  1998-12       Impact factor: 4.307

Review 7.  Abiotrophic gene action in Homo sapiens: potential mechanisms and significance for the pathobiology of aging.

Authors:  G M Martin
Journal:  Genetica       Date:  1993       Impact factor: 1.082

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.